We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
VERU

Price
3.01
Stock movement down
-0.49 (-14.00%)
Company name
Veru Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
44.10M
Ent value
41.96M
Price/Sales
3.13
Price/Book
1.17
Div yield
9302.33%
Div growth
-
Growth years
2
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
42.01%
1 year return
-99.64%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-30

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share280.00
Dividend yield9302.33%
Payout frequencyQuarterly
Maximum yield9302.33%
Average yield1468.77%
Minimum yield21.88%
Discount to avg yield84.21%
Upside potential533.34%
Yield as % of max yield100.00%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield9302.33%
Current yield distribution-
Yield at 100% (Min)21.88%
Yield at 90%37.12%
Yield at 80%40.30%
Yield at 50% (Median)50.96%
Yield at 20%793.20%
Yield at 10%7547.22%
Yield at 0% (Max)9302.33%

Dividend per share

Loading...
Dividend per share data
Years of growth2 years
CCC status-
Dividend per share280.00
Payout frequencyQuarterly
Ex-div date28 Apr 2014
EPS (TTM)-
EPS (1y forward)-1.92
EPS growth (5y)42.01%
EPS growth (5y forward)-

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
VERUS&P500
DGR MR16.67%-13.74%
DGR TTM12.00%6.60%
DGR 3 years-5.24%
DGR 5 years-5.40%
DGR 10 years-7.07%
DGR 15 years-6.12%
Time since last change announced4611 days
EPS growth (5y)42.01%
EPS growth (5y forward)-

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM--
Average--
Forward-14621.41%-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales3.13
Price to Book1.17
EV to Sales2.98

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count14.65M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-1.92

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash15.01M
Net receivables0.00
Total current assets16.19M
Goodwill6.88M
Intangible assets0.00
Property, plant and equipment3.84M
Total assets27.33M
Accounts payable2.54M
Short/Current long term debt3.25M
Total current liabilities6.68M
Total liabilities11.99M
Shareholder's equity0.00
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open2.85
Daily high3.13
Daily low2.76
Daily Volume766K
All-time high23780.00
1y analyst estimate19.75
Beta-1.01
EPS (TTM)-
Dividend per share280.00
Ex-div date28 Apr 2014
Next earnings date1 Dec 2025

Downside potential

Loading...
Downside potential data
VERUS&P500
Current price drop from All-time high-99.99%-1.10%
Highest price drop-99.99%-19.00%
Date of highest drop30 Oct 20258 Apr 2025
Avg drop from high-97.95%-2.76%
Avg time to new high-5 days
Max time to new high266 days89 days
COMPANY DETAILS
VERU (Veru Inc) company logo
Marketcap
44.10M
Marketcap category
Small-cap
Description
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Employees
210
Investor relations
-
SEC filings
CEO
Mitchell Shuster Steiner
Country
USA
City
Miami
Stock type
Common stock
CCC status
-
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...